Scott M. Brinker Acquires 2,930 Shares of Healthpeak Properties, Inc. (NYSE:DOC) Stock

Key Points

• Scott M. Brinker, CEO of Healthpeak Properties, acquired **2,930 shares** of the company’s stock at an average cost of **$17.06 per share**, totaling approximately **$49,985.80**.
• Healthpeak Properties has announced a **monthly dividend** of **$0.1017 per share**, which translates to an annualized yield of **7.17%** and is set to be paid on **September 30th**.
• Recent analysts' assessments have led to **reduced price targets** for the stock, with recommendations varying from **"sell" to "outperform"**, and the average price target now standing at **$23.00**.

Healthpeak Properties, Inc. (NYSE:DOC - Get Free Report) CEO Scott M. Brinker purchased 2,930 shares of the firm's stock in a transaction that occurred on Thursday, July 31st. The shares were bought at an average cost of $17.06 per share, for a total transaction of $49,985.80. Following the completion of the acquisition, the chief executive officer directly owned 210,416 shares in the company, valued at $3,589,696.96. The trade was a 1.41% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Healthpeak Properties Trading Down 1.2%

Shares of NYSE:DOC traded down $0.21 during trading on Thursday, reaching $17.02. The stock had a trading volume of 4,446,502 shares, compared to its average volume of 5,907,048. The firm's fifty day moving average is $17.68 and its 200 day moving average is $18.79. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.35 and a current ratio of 1.28. Healthpeak Properties, Inc. has a 52 week low of $16.64 and a 52 week high of $23.26. The stock has a market cap of $11.82 billion, a price-to-earnings ratio of 70.92, a P/E/G ratio of 2.22 and a beta of 1.03.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.46. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The company had revenue of $694.35 million for the quarter, compared to the consensus estimate of $697.14 million. During the same quarter in the previous year, the company earned $0.45 EPS. Healthpeak Properties's quarterly revenue was down .2% compared to the same quarter last year. As a group, equities analysts forecast that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently announced a monthly dividend, which will be paid on Tuesday, September 30th. Investors of record on Friday, September 19th will be given a dividend of $0.1017 per share. The ex-dividend date of this dividend is Friday, September 19th. This represents a $1.22 dividend on an annualized basis and a dividend yield of 7.17%. Healthpeak Properties's payout ratio is presently 508.33%.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the stock. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Healthpeak Properties by 584.6% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 9,218,848 shares of the real estate investment trust's stock worth $186,405,000 after buying an additional 7,872,150 shares during the last quarter. Nuveen LLC acquired a new position in Healthpeak Properties during the first quarter worth $124,113,000. Resolution Capital Ltd acquired a new position in Healthpeak Properties during the fourth quarter worth $122,795,000. Long Pond Capital LP acquired a new position in Healthpeak Properties during the fourth quarter worth $86,885,000. Finally, Invesco Ltd. raised its holdings in Healthpeak Properties by 20.7% during the first quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust's stock worth $467,311,000 after buying an additional 3,967,830 shares during the last quarter. Institutional investors and hedge funds own 93.57% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the stock. Evercore ISI reduced their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. Wall Street Zen lowered shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Monday, July 7th. Scotiabank lowered shares of Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and reduced their target price for the stock from $21.00 to $19.00 in a report on Tuesday. Wedbush reduced their target price on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. Finally, Robert W. Baird set a $21.00 target price on shares of Healthpeak Properties and gave the stock an "outperform" rating in a report on Wednesday. One analyst has rated the stock with a sell rating, three have issued a hold rating and eight have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $23.00.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.